i3 Verticals Inc-2026年度季度报告

i3 Verticals, Inc. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files). YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No As of February5, 2026, there were 22,094,170 outstanding shares of Class A common stock, $0.0001 par value per share, and 8,381,681outstanding shares of Class B common stock, $0.0001 par value per share. TABLE OF CONTENTS 334 PART I. FINANCIAL INFORMATION PART II. OTHER INFORMATIONItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits i3 Verticals, Inc. i3 Verticals, Inc. (In thousands, except share and per share amounts) i3 Verticals, Inc. (In thousands, except share amounts) (In thousands) i3 Verticals, Inc. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED) (In thousands) The following tables provide reconciliations of cash, cash equivalents and restricted cash reported within the condensedconsolidated balance sheets to that shown in the condensed consolidated statements of cash flows: i3 VERTICALS, Inc. NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)(in thousands, except unit, share and per share amounts) 1. ORGANIZATION AND OPERATIONS i3 Verticals, Inc. (the “Company”) was formed as a Delaware corporation on January 17, 2018. The Company was formedfor the purpose of completing an initial public offering (“IPO”) of its Class A common stock and other related transactions inorder to carry on the business of i3 Verticals, LLC and its subsidiaries. i3 Verticals, LLC was founded in 2012 and deliverssoftware solutions seamlessly integrated with our proprietary payment facilitator platform to customers in strategic vertical In connection with the IPO, the Company completed certain reorganization transactions, which, among other things,resulted in i3 Verticals, Inc. being the sole managing member of i3 Verticals, LLC (the “Reorganization Transactions”).Following the completion of the IPO and Reorganization Transactions, the Company is a holding company and the principalasset that it owns are the common units of i3 Verticals, LLC. i3 Verticals, Inc. operates and controls all of i3 Verticals, LLC'soperations and, through i3 Verticals, LLC and its subsidiaries, conducts i3 Verticals, LLC's business. i3 Verticals, Inc. has a 2. DISCONTINUED OPERATIONS Healthcare RCM Business Divestiture During the three months ended June 30, 2025, i3 Verticals, LLC and i3 Healthcare Solutions, LLC, a wholly-ownedsubsidiary of i3 Verticals, LLC (“Healthcare RCM Seller,” and collectively with i3 Verticals, LLC, the “Healthcare RCM SellerParties”), completed the sale of the equity interests of certain wholly-owned subsidiaries of the Healthcare RCM Seller (the“Healthcare RCM Acquired Entities”) which owned and operated the Company's healthcare revenue cycle managementbusiness, including its associated proprietary technology (the “Healthcare RCM Business”), to Infinx, Inc. (“Healthcare RCMBuyer”), a Texas corporation, pursuant to the terms of that certain Securities Purchase Agreement dated as of May 5, 2025, byand among Healthcare RCM Buyer and the Healthcare RCM Seller Parties (the “Healthcare RCM Purchase Agreement;” thetransactions contemplated by the Healthcare RCM Purchase Agreement, the “Healthcare RCM Transactions”). In addition, NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)(in thousands, except unit, share and per share amounts) At the closing of the transactions contemplated by the Healthcare RCM Purchase Agreement, the Company entered into atransition services agreement with Infinx ("Infinx TSA"), pursuant to which, among other things, the Company or affiliatesthereof are providing certain information te